CSS
ANIP icon

Cubist Systematic Strategies’s ANI Pharmaceuticals ANIP Stock Holding History

Cubist Systematic Strategies’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.04M Buy
+44,138
New +$3.6M 0.02% 1095
2024
Q2 		– Sell
-55,683
Closed -$3.85M – 2934
2024
Q1 		$3.85M Buy
55,683
+21,939
+65% +$1.32M 0.02% 1145
2023
Q4 		$1.86M Buy
33,744
+5,160
+18% +$284K 0.01% 1574
2023
Q3 		$1.66M Buy
28,584
+25,114
+724% +$1.45M 0.01% 1500
2023
Q2 		$187K Sell
3,470
-3,465
-50% -$154K ﹤0.01% 2843
2023
Q1 		$275K Buy
+6,935
New +$292K ﹤0.01% 3048
2022
Q4 		– Sell
-8,751
Closed -$281K – 4218
2022
Q3 		$281K Buy
+8,751
New +$300K ﹤0.01% 3557
2022
Q1 		– Sell
-25,869
Closed -$1.19M – 3537
2021
Q4 		$1.19M Buy
+25,869
New +$1.11M 0.01% 1787
2020
Q3 		– Sell
-12,499
Closed -$404K – 2476
2020
Q2 		$404K Buy
+12,499
New +$448K 0.01% 1700
2020
Q1 		– Sell
-6,105
Closed -$376K – 2147
2019
Q4 		$376K Sell
6,105
-1,719
-22% -$114K 0.01% 1710
2019
Q3 		$570K Buy
+7,824
New +$585K 0.01% 1235
2019
Q1 		– Sell
-7,805
Closed -$351K – 2227
2018
Q4 		$351K Buy
+7,805
New +$409K 0.02% 1171
2018
Q2 		– Sell
-18,027
Closed -$1.05M – 1771
2018
Q1 		$1.05M Buy
+18,027
New +$1.14M 0.06% 413
2016
Q1 		– Sell
-4,744
Closed -$214K – 1593
2015
Q4 		$214K Buy
+4,744
New +$204K 0.01% 1316
2015
Q3 		– Sell
-17,100
Closed -$1.06M – 1853
2015
Q2 		$1.06M Buy
+17,100
New +$1.02M 0.05% 532
2015
Q1 		– Sell
-3,651
Closed -$206K – 1876
2014
Q4 		$206K Buy
+3,651
New +$161K 0.01% 1493

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Cubist Systematic Strategies's ANIP Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in ANI Pharmaceuticals (ANIP) in Q3 2025: 44,138 shares worth $4.04M. The stake represents 0.02% of the portfolio and ranks #1095 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in ANIP as recently as Q1 2024.

Cubist Systematic Strategies first reported a position in ANIP in Q4 2014 and has held it in 16 quarters since. 269 funds tracked by Wall St. Rank hold ANIP as of Q3 2025.

  • Cubist Systematic Strategies held 44,138 shares of ANI Pharmaceuticals worth $4.04M as of Q3 2025.
  • ANI Pharmaceuticals was a new Cubist Systematic Strategies position in Q3 2025.
  • ANI Pharmaceuticals made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1095 holding.
  • Cubist Systematic Strategies first reported a position in ANI Pharmaceuticals in Q4 2014 and has held it in 16 quarters since.
  • 269 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.